Correlation Between Virax Biolabs and ContraFect Corp
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and ContraFect Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and ContraFect Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and ContraFect Corp, you can compare the effects of market volatilities on Virax Biolabs and ContraFect Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of ContraFect Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and ContraFect Corp.
Diversification Opportunities for Virax Biolabs and ContraFect Corp
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Virax and ContraFect is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and ContraFect Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ContraFect Corp and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with ContraFect Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ContraFect Corp has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and ContraFect Corp go up and down completely randomly.
Pair Corralation between Virax Biolabs and ContraFect Corp
If you would invest 68.00 in Virax Biolabs Group on October 12, 2024 and sell it today you would earn a total of 166.00 from holding Virax Biolabs Group or generate 244.12% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 0.53% |
Values | Daily Returns |
Virax Biolabs Group vs. ContraFect Corp
Performance |
Timeline |
Virax Biolabs Group |
ContraFect Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Virax Biolabs and ContraFect Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Virax Biolabs and ContraFect Corp
The main advantage of trading using opposite Virax Biolabs and ContraFect Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, ContraFect Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ContraFect Corp will offset losses from the drop in ContraFect Corp's long position.Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
ContraFect Corp vs. Palisade Bio | ContraFect Corp vs. Allarity Therapeutics | ContraFect Corp vs. Cns Pharmaceuticals | ContraFect Corp vs. Windtree Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |